Stifel Financial
ORIC icon

Stifel Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Stifel Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
23,899
+10,409
+77% +$118K ﹤0.01% 3176
2025
Q4 		$110K Buy
+13,490
New +$155K ﹤0.01% 3479

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Stifel Financial's ORIC Position: Q1 2026 in Review

Stifel Financial increased its Oric Pharmaceuticals (ORIC) stake by 77% in Q1 2026, buying an estimated $118K and bringing the position to 23,899 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

Stifel Financial first reported a position in ORIC in Q4 2025 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Stifel Financial held 23,899 shares of Oric Pharmaceuticals worth $303K as of Q1 2026.
  • Stifel Financial bought 10,409 Oric Pharmaceuticals shares in Q1 2026, an estimated $118K.
  • Oric Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3176 holding.
  • Stifel Financial first reported a position in Oric Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.